59th Annual AES Meeting
December 2, 2005
WASHINGTON, Dec. 2 /PRNewswire/ —
WHO: You are invited to join leading medical and scientific experts at the largest epilepsy-related conference in the nation as they explore new research in the diagnosis, treatment and scientific understanding of epilepsy, a disorder that affects approximately 100 million people worldwide. WHAT: The American Epilepsy Society’s 59th Annual Meeting WHERE: Washington Convention Center 801 Mount Vernon Place, N.W., Washington, DC Press room is located at the convention center in room #305 WHEN: Meeting: Friday, December 2nd to Tuesday, December 6th, 2005 Platform Presentations: Monday, December 5th, 3:00 p.m.- 6:00 p.m. Poster Sessions: Sunday, December 4th, noon-5:00p.m Monday, December 5th, 8:00 a.m. to 5:00 p.m. Tuesday, December 6th, 8:00 a.m. to 1:00 p.m. Press Room Hours: Friday, December 2nd, 2:00 p.m.- 7:30 p.m. Saturday, December 3rd, 8:00 a.m.- 6:00 p.m. Sunday, December 4th, 8:00 a.m.- 6:00 p.m. Monday, December 5th, 8:00 a.m.- 6:00 p.m. Tuesday, December 6th, 8:00 a.m.- 5:00 p.m. WHY: Find out the latest data on epilepsy, the most common neurological disorder of the brain including: * How do treatments impact psychiatric and behavioral adverse events in pediatric patients? * What treatments are effective for elderly patients diagnosed with epilepsy? * Beyond pharmacotherapy; what alternative treatments are available to improve a patient’s quality of life?
Contact Christer Osterling at 850.586.7500 / costerling@aesnet.org or Lindsey Smith at 212.229.8481 or lsmith@aesnet.org to:
* Register * Obtain advance materials or abstracts * Arrange interviews with researchers and physicians Sunday, December 4th Poster Sessions: noon – 5:00p.m. Highlights from today’s meeting include data on the following topics: Epilepsy and Women * Twelve year interim results from an international observational study of pregnancy outcomes following (Poster #212) * Five Year Data from the Australian Pregnancy Registry for Women on Antiepileptic Medication (Poster #219) * Antiepileptic Drug Use and Birth Rate in Patients with Epilepsy (Poster #207) Monday, December 5th Platform Presentations: 3:00p.m. – 6:00 p.m. Poster Sessions: 8:00 a.m. – 5:00 p.m. Highlights from today’s meeting include data on the following topics: Pediatrics * Evaluation of the Relative Risk of Psychiatric and Behavioral Adverse Events in Pediatric Patients with Refractory Partial Seizures Treated with levetiracetam — Impact of Prior History and a Comparison with Adult Data (Poster # 2.338a) * Seizure-Free Rate in Patients with Partial Seizures Receiving Oxcarbazepine Monotherapy: A Pooled Analysis (Poster #365) * Seizure Control with Levetiracetam in Juvenile Myoclonic Epilepsies (Poster #339) * Effect of in utero exposure to anti-epileptic medication on the cognitive abilities of school age children (Platform Series A.02) * Epilepsy. Use of Second Generation AntiEpileptic Drugs and Association of Behavioral and Psychiatric Events in Children (Poster #303) * Use of Levetiracetam in Juvenile Myoclonic Epilepsy (Poster #333) * Clobazam for the Treatment of Intractable Childhood Epilepsy (Poster #332) Epilepsy and the Elderly * An International Multicenter Double-Blind Randomized Comparative Trial of Lamotrigine and Slow Release Carbamazepine in Elderly Patients with Newly Diagnosed Epilepsy (Poster #372) Vagal Nerve Stimulation * Long Term VNS Experience in Normal and Mentally Retarded Adults and Children(Poster #413) Implants * Safety and evidence for efficacy of an implantable responsive neurostimulator (RNS(R)) for the treatment of medically intractable partial onset epilepsy in adults (Poster #397) Alternative Treatments * A Modified Atkins Diet is Effective for the Treatment of Intractable Pediatric Epilepsy: Results from a Prospective Trial (Platform Series A.01) * Beneficial Effects on Sleep of Ketogenic Diet in Children with Therapy Resistant Epilepsy (Poster #404) Health Economics * Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable epilepsy: How many years to divide out pre-surgical explorations and surgery costs? (Poster #450) Concomitant Conditions * Carbamazepine May Induce Osteoporosis by Increasing Bone Turnover in Postmenopausal Women (Poster #260) * Children Treated for Epilepsy Have Significant Reduction in Bone Mineral Density (Poster #211) * Double-Blind Evaluation of the Cognitive Effects of Lamotrigine Versus Topiramate Adjunctive Therapy (Poster #225) Adjunct Treatment Options * A Double-Blind, Placebo-Controlled Evaluation of Lamotrigine for Obesity (Poster #267) * Pregabalin as Add-On Treatment for Partial Seizures With or Without Secondary Generalizations: Efficacy, Safety, and Tolerability Findings from the Analysis of Four Randomized Clinical Trials (Poster #219) Idiopathic and Localization Related Epilepsy * Prospective outcome of Levetiracetam efficacy in refractory idiopathic generalized and localization related epilepsy in adults (Poster #266) Tuesday, December 6th Poster Sessions: 8:00 a.m. – 1:00 p.m. Highlights from today’s meeting include data on the following topics: Epilepsy and Women * Distribution of Seizures During the Menstrual Cycle in Women with Epilepsy (Poster #190) Epilepsy in the Elderly * Epilepsy in Seniors: Knowledge and Practice Patterns among 221 Health Care Providers: An Epilepsy Foundation Study (Poster #258) Alternative Treatments * A Controlled Clinical Trial of Direct Current Stimulation in Patients with Refractory Epilepsy (Poster #157)
To obtain copies of full abstracts contact Christer Osterling at 850.586.7500 / costerling@aesnet.org or Lindsey Smith at 212.229.8481/ lsmith@aesnet.org
American Epilepsy Society
CONTACT: Christer Osterling, +1-850-586-7500, costerling@aesnet.org, orLindsey Smith, +1-212-229-8481, lsmith@aesnet.org, both for American EpilepsySociety